Academic Emergency Medicine · 2018 · 11 citations · 7 references
Public HealthInfectious DiseasesPediatricsAdolescent HealthAdolescent MedicineHiv PreventionAdolescent Health CareAdolescent Hiv PreventionHiv DiagnosisHiv EpidemiologyHiv TestingSexually Transmitted InfectionsAcquired Immunodeficiency SyndromeAdolescent Hiv TestingEarly Hiv DiagnosisHiv PrevalenceHiv Serologic TestingHuman Immunodeficiency Virus TestingRoutine Hiv Testing
Across the United States, rates of new human immunodeficiency virus (HIV) diagnosis have declined.1 Despite this, adolescents have experienced increases in HIV diagnosis rates.1, 2 It is estimated that half of adolescents are unaware of their diagnosis1, 3 and that, on average, they are infected with HIV for nearly 3 years prior to diagnosis.2 The Centers for Disease Control and Prevention (CDC) recommends routine universal HIV screening for everyone over age 13 in health care settings. These recommendations have not been widely implemented in pediatrics,4, 5 where HIV testing is often offered only to select high-risk populations or as part of a diagnostic work-up. Nearly half of students report a history of sexual activity, yet only 10% of students report ever having been tested for HIV.6 Georgia had the highest rate of new diagnoses of HIV in the United States in 2016,7 with the highest found in the Atlanta metropolitan area and in young adults 20 to 29 years.7 Twenty percent were diagnosed with Stage 3 HIV (previously called acquired immunodeficiency syndrome, AIDS) within 1 year, indicating that diagnosis occurred late in the disease course.7 Although a large, urban safety-net general ED in Atlanta has successfully implemented opt-out HIV screening and has found a new HIV diagnosis rate greater than 1%,8 the extent of pediatric HIV in this high-prevalence setting is unknown. We sought to describe the characteristics of pediatric patients diagnosed with HIV through targeted and diagnostic testing in a pediatric health care system over a 5-year period through a retrospective chart review of patients newly diagnosed with HIV at any of three hospitals that make up Children's Healthcare of Atlanta (CHOA) and of linkage to follow-up HIV care at the Ponce Family and Youth Clinic (PFYC) of Grady Health Systems. Patients were included if they were seen at a CHOA hospital and an HIV antibody or combination antigen/antibody test was sent between January 1, 2013, and December 31, 2017. Patients with a known HIV diagnosis at the time of testing were excluded, as were infants less than 18 months who were known to be HIV-exposed at birth. This study was approved by the CHOA Institutional Review Board and the Grady Research Oversight Committee. Charts from inpatient, outpatient, and ED settings were reviewed for patients with positive (reactive) HIV test results; information was collected on patient characteristics, including chronic conditions, presenting symptoms, laboratory results, and any additional new diagnoses. Confirmed cases and HIV stage were determined in accordance with CDC surveillance case definitions.9 Time to follow-up and confirmatory testing were obtained from PFYC records. Descriptive statistics were utilized to summarize patient and test characteristics (Table 1). Between 2013 and 2017, a total of 6,292 HIV tests were sent and 41 patients (0.7%) had positive results. Thirty-four (83%) were confirmed cases of new HIV and six (15%) were false positives. One patient with a positive screen (antigen-positive, antibody-negative) was lost to follow-up without having confirmatory testing. Of 27 patients with CD4 counts available at diagnosis, 14 (41%) were diagnosed with Stage 3 disease (AIDS) on the basis of low CD4 count for age. Eight (24%) had a Stage 3 defining illness, such as Pneumocystis jirovecii pneumonia (PJP) and mycobacterial infection. Although 27 patients with confirmed HIV (79%) were adolescents, seven (21%) were infants or children without known risk factors or exposure for HIV acquisition; two children were recent immigrants and five were US-born infants who, at the time of presentation, were not known to have had HIV exposure at birth. Twenty-nine patients with confirmed HIV (85%) had documented linkage to HIV care; the median time to follow-up was 7 days. One infant with PJP did not survive the presenting illness. Four patients (12%) were lost to follow-up. Of these, one adolescent who screened positive in the ED was called back to the ED for diagnosis disclosure and referral to PYFC. This patient was thereafter lost to follow-up and was admitted to an adult hospital 2 years later with PJP and a CD4 count of 16 copies/mL. Our findings are important for many reasons. Early diagnosis of HIV is essential in allowing individuals to receive prompt antiretroviral treatment, which is effective in slowing or preventing the progression of HIV and in reducing HIV-related mortality. Early HIV diagnosis is also critical in preventing HIV transmission, as individuals who are aware of their HIV diagnosis are more likely to reduce high-risk behaviors that lead to HIV spread.3 Forty-one percent of the patients in our study were diagnosed with Stage 3 disease, indicating that they were diagnosed late in their disease course. The high rate of late-stage disease at the time of diagnosis is a striking call to increase surveillance in accordance to CDC recommendations and identify children and adolescents with HIV earlier in the course of their illness. Unexpectedly, seven patients were infants or children who did not have known perinatal HIV exposure. Five of these children's parents were able to be tested and all tested parents were ultimately found to be HIV-positive. This is a reflection of the overall high incidence of HIV in Atlanta and the need for widespread efforts across the region to improve diagnosis and treatment of individuals with HIV. This retrospective chart review is subject to the inherent bias of this study design. The study took place within a single children's hospital network in a region of high HIV prevalence. The findings may not be generalizable to areas with lower HIV prevalence. In an urban area with high HIV prevalence, a significant number of children and adolescents were diagnosed with HIV over a 5-year period. Many of these patients were found to have late-stage HIV at the time of diagnosis, indicating a critical need for earlier identification of pediatric HIV. Although targeted and diagnostic HIV testing is effective in identifying new HIV cases, this strategy will miss children who are asymptomatic early in their disease course or who do not disclose their risk factors. As many adolescents use the ED as their primary source of care, implementation of CDC-recommended universal screening in pediatric EDs may save lives, particularly in communities with high HIV prevalence similar to Atlanta.
7
Trends in Diagnoses of HIV Infection in the United States, 2002-2011
Anna Satcher Johnson, H. Irene Hall, Xiaohong Hu et al. · JAMA · 2014 · 134 citations · Full text
Public Health, Infectious Disease Control, Preventive Medicine +16